← Eichor
Study identifier: NCT06483659 Synced from ClinicalTrials.gov · July 27, 2026
● Recruiting

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

Condition: Postoperative Pain  ·  Sponsor: Brigham and Women's Hospital

PhasePhase 2
Planned participants152
Who can joinFemale, 18 Years to 65 Years
Healthy volunteersYes

About this study

This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

John J. Kowalczyk, MD  ·  617-732-8220  ·  jkowalczyk@bwh.harvard.edu

Rusul I Al-Ani  ·  617-525-6483  ·  rual-ani@bwh.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Brigham and Women's HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06483659